Brain Aging Study
HMRI’s Brain Aging Study began more than 20 years ago. Today, scientists are advancing research on Alzheimer’s disease, focusing on noninvasive biomarkers for early detection of the disease and neurodegeneration at the early stages of the disease, and perhaps before the onset of clinical symptoms. Using longitudinal studies, researchers investigate biomarkers for early detection, changes in cognition, and comorbidities. The study aims to help ameliorate health disparities among underserved minorities by removing barriers to healthcare access with low-cost, noninvasive tests for the early detection of neurodegenerative diseases.
